Prealbumin (Transthyretin)
Prealbumin, also known as transthyretin, is a protein that is synthesized in the liver. Its main function is to bind and transport T4 and retinol/vitamin A. Although thyroxine binds to prealbumin, only a small percentage of total thyroxine is transported by prealbumin in normal individuals because thyroxine-binding globulin, which is a main thyroxine transporter, has a much higher affinity for thyroxine. Prealbumin also binds vitamin A through retinol-binding protein (RBP), which complexes with prealbumin. The prealbumin-RBP complex is large enough to prevent rapid removal of retinol-binding protein by kidney filtration. Prealbumin serum levels are used mainly to assess nutritional status due to its short half-life and the quick shift in concentration when diet changes. It is a good indicator of nutrition status in surgery patients or patients having replacement nutrition therapy.
Prealbumin levels will be significantly decreased in malnutrition and is more sensitive than albumin when determining nutrition status. Prealbumin levels will decrease when liver function is impaired as in hepatitis, cirrhosis, or malignancy. Decreased levels will also be seen when inflammation is present due to the fact that prealbumin is a negative acute phase reactant and its level is inversely proportional to C-reactive protein; hence, prealbumin levels decline as CRP levels rise and visa versa. Increased prealbumin levels are found during glucocorticosteroid intake and Hodgkin’s disease. Preambumins are also associated with formation of amyloid fibrils and amyloid disease. There are 38 different forms of prealbumin partly due to point mutations; some of these non-standard forms result is dissociation of the normal tetramer with formation of amyloid fibrils. The normal form can also form amyloid fibrils, but the mutated forms lead to amyloid disease at an earlier age.
- In diagnosis of liver disease
- To diagnose and monitor patients with malnutrition
- Evaluation of total parenteral nutrition
Increased in:
- During glucocorticosteroid intake
- Hodgkin’s lymphoma
- Chronic renal failure
- Amyloid disease
Decreased in:
- Liver diseases that decreases hepatic synthesis (cirrhosis)
- Inflammation
- Malignancy
- Protein-wasting diseases of the gut or kidney
- During estrogen administration
- Cystic fibrosis
- Chronic illness
0.2 - 0.4 g/L (3.64 - 7.28 μmol/L or 20.0 - 40.0 mg/dL)
Serum (SST).
Stability
- Ambient: 5-7 days
- Refrigerated: 7-14 days
- Frozen: 60 days
- Clin Chim Acta. 1981 Jul 18;114(1):69-74. [PMID: 7249376]
- J Infus Nurs. 2005 Mar-Apr;28(2):108-17. [PMID: 15785331]
- Ann Clin Lab Sci. 1982 May-Jun;12(3):158-62. [PMID: 6807189]
- Burtis C, Ashwood E, and Bruns D. Fundamentals of Clinical Chemistry. St. Louis: Saunders (2008).